RxDoctor Payments Data

Ellen Spremulli

Hematology & Oncology · Anniston, ALNPI 1619922648

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (56.8%), consulting fees and education — rather than concentrated in one kind of arrangement. 47 manufacturers reported payments, led by Genentech USA, Inc. at 39.8% of the total. Reporting peaked in 2020 at $2,732 and has fallen 99.4% since, to $15 in 2024. That places this record below the midpoint for hematology & oncology clinicians in AL, where the typical reported total is $7,159.

$6,300in general payments, 2019–2025

Across 233 payments — averaging $27.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech USA, Inc.$3K
  • E.r. Squibb & Sons, L.L.C.$314
  • Novartis$267
  • Merck$256
  • Bristol Myers Squibb$242
  • AstraZeneca$216
  • plus $2K from 41 others
$8,800in research payments, 2019–2025

Across 1 payment — averaging $8800.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Puma Biotechnology, Inc.$9K

What the payments were for

  • Consulting fees$2,47539%
  • Food & beverage$3,57957%
  • Education$2454%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,300 in reported general payments places this provider in the 45th percentile of 177 hematology & oncology providers in Alabama.

See all hematology & oncology providers in Alabama →

Other hematology & oncology in Anniston

See the full list for Alabama →

Where these figures come from

Is this you, or does something look wrong? →